What are the causes of lymphedema, particularly in women with a history of breast cancer treatment or genetic conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Lymphedema

Lymphedema results from abnormalities or damage to the lymphatic system, leading to accumulation of protein-rich interstitial fluid and fibroadipose tissue, with causes divided into primary (congenital lymphatic abnormalities) and secondary (acquired damage from surgery, radiation, infection, or malignancy). 1, 2

Primary Lymphedema

  • Primary lymphedema stems from congenital lymphatic system abnormalities that impair lymphatic transport capacity from birth or develop later in life due to inherent defects in lymphatic vessels or lymph nodes. 1, 3

Secondary Lymphedema Causes

Cancer Treatment-Related (Most Common in Women)

Surgical lymph node dissection is the leading cause of secondary lymphedema, particularly:

  • Axillary lymph node dissection (ALND) for breast cancer causes lymphedema in 30-50% of patients, with risk approximately four times higher than sentinel lymph node biopsy. 4, 5, 6
  • Sentinel lymph node biopsy carries substantially lower risk (5.6-7.9%) compared to full ALND (13.5-28.2%). 6
  • Pelvic surgery with lymph node dissection is the most common cause of unilateral lower extremity lymphedema. 7
  • The extent of lymph node removal matters: removing five or more lymph nodes substantially increases lymphedema risk. 1, 2

Radiation therapy damages lymphatic channels and increases risk:

  • Radiation to supraclavicular lymph nodes or axilla significantly elevates lymphedema risk, especially when combined with surgery. 8, 2
  • Pelvic radiation damages lymphatic channels and increases lower extremity lymphedema risk. 7
  • Combined surgery and radiation therapy creates additive risk beyond either treatment alone. 2

Malignancy-Related

  • Malignancy causing lymphatic obstruction through direct tumor compression or invasion of lymphatic vessels can cause secondary lymphedema. 7

Infection-Related

  • Recurrent infections (particularly cellulitis) in affected areas damage lymphatic vessels and increase lymphedema risk. 2
  • Chronic venous insufficiency can contribute to lower extremity lymphedema development. 7

Major Risk Factors That Exacerbate or Trigger Lymphedema

Obesity (BMI >30 kg/m²) is a critical modifiable risk factor:

  • Obesity exacerbates lymphedema severity and correlates with higher International Society of Lymphology stages. 7
  • Weight loss should be mandated for overweight/obese patients to prevent or reduce lymphedema risk. 8, 7

Timeline of Development

  • 70% of breast cancer-related lymphedema occurs within two years of surgery, 90% within three years, with approximately 1% annual incidence thereafter. 6
  • Lymphedema may occur immediately after treatment or develop years later (up to 11-30 years post-treatment), making lifelong surveillance necessary. 8, 4

Critical Clinical Pitfall

Many patients with no traditional high-risk variables (such as mastectomy, ALND, or radiation) still develop lymphedema, indicating that risk stratification is imperfect and all patients who undergo breast surgery or radiation require monitoring. 6

References

Guideline

Lymphedema Management and Differentiation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lymphedema Causes and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Breast cancer-related lymphedema.

Mayo Clinic proceedings, 2005

Research

The legacy of lymphedema: Impact on nursing practice and vascular access.

Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2019

Guideline

Unilateral Lower Extremity Lymphedema Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.